← Open Payments lookup

HELEN KIM: Open Payments

NPI 1497380356 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,129 in 90 payments from 19 companies in 2025. Trend: 2023 $1,068 · 2024 $1,473 · 2025 $2,129

Food & beverage: $2,129
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.17$471
Vanda Pharmaceuticals Inc.10$288
ABBVIE INC.16$272
Otsuka America Pharmaceutical, Inc.10$246
E.R. Squibb & Sons, L.L.C.5$199
Teva Pharmaceuticals USA, Inc.8$140
Alkermes, Inc.5$103
Indivior Inc.3$77
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$66
Braeburn Inc.2$43

Products named: INGREZZA, VRAYLAR, HETLIOZ, COBENFY, ABILIFY ASIMTUFII, REXULTI, ARISTADA, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.